Transport Media Market Size and Share Analysis by Product Type, Application, Indication, End User

Description

The transport media market is estimated to reach USD 3,101.3 million in 2023, which will increase to USD 4,210.6 million, with a 4.6% compound annual growth rate, by 2030.

The growth of this industry is because of the rising R&D on viral illnesses, increasing need for pre-clinical and diagnostic testing, and the surging occurrence of infectious ailments like influenza and herpes.

For example, in 2022, around 400,000 individuals died from influenza globally. Likewise, approximately 4 billion individuals have herpes. Moreover, the growing count of government initiatives to enhance the acceptance of testing kits is also boosting the industry.

The viral transport media category, based on product type, is leading the industry, with a 35% share, in 2023. This can be because of the unexpected outbreak of infectious ailments like COVID-19 and monkeypox, which boost the requirement for testing and diagnosis among the infected people.

Furthermore, the growing consciousness of treatment and diagnosis during the pandemic of COVID-19 has increased the requirement for related products for detecting various other infections.

The viral diseases category, on the basis of indication, is dominating the transport media market. Furthermore, the category will also advance at the fastest rate during this decade. This can be primarily because of the surging incidence of viral ailments like influenza, monkeypox, herpes, COVID-19, respiratory syncytial virus, and Varicella zoster.

Moreover, among these ailments, the influenza and COVID-19 virus are the most contagious respiratory ailments, therefore, they are a serious cause for worry globally.

The diagnostic laboratories category, based on end user, is the largest contributor to the industry. This is because of the increase in the need for testing as well as diagnosis of COVID-19. This has powered the formation of diagnostic labs and increased their workload.

North America is dominating the industry. This is because of the surging number of diagnostic tests, rising R&D on infectious ailments, well-established healthcare system, and the existence of numerous pharma and biotech businesses.

Basically, the surging occurrence of infectious illnesses, particularly viral ailments, is a main factor that assists in revenue generation for industry players.

APAC will advance at the fastest compound annual growth rate during this decade, because of the rising prevalence of infectious illnesses like Lyme disease, tuberculosis, and COVID-19.

Moreover, the number of people with infectious illnesses is quite high in APAC, particularly in India and China. Therefore, several industry players have arrived to satisfy the vast unmet necessity for diagnosis.

It is because of the increasing research & development in viral ailments and the mounting incidence of infectious illnesses, the transport media industry will continue to progress in the coming years.

Product Code: 12724

Chapter 1. Research Scope

1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by product type
- 1.4.2. Market size breakdown, by application
- 1.4.3. Market size breakdown, by indication
- 1.4.4. Market size breakdown, by end user
- 1.4.5. Market size breakdown, by region
- 1.4.6. Market size breakdown, by country
1.5. Market Data Reporting Unit
- 1.5.1. Value
1.6. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
5.2. Impact of COVID-19
5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes

Chapter 6. Global Market

6.1. Overview
6.2. Market Revenue, by Product Type (2017-2030)
6.3. Market Revenue, by Application (2017-2030)
6.4. Market Revenue, by Indication (2017-2030)
6.5. Market Revenue, by End User (2017-2030)
6.6. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

7.1. Overview
7.2. Market Revenue, by Product Type (2017-2030)
7.3. Market Revenue, by Application (2017-2030)
7.4. Market Revenue, by Indication (2017-2030)
7.5. Market Revenue, by End User (2017-2030)
7.6. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

8.1. Overview
8.2. Market Revenue, by Product Type (2017-2030)
8.3. Market Revenue, by Application (2017-2030)
8.4. Market Revenue, by Indication (2017-2030)
8.5. Market Revenue, by End User (2017-2030)
8.6. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

9.1. Overview
9.2. Market Revenue, by Product Type (2017-2030)
9.3. Market Revenue, by Application (2017-2030)
9.4. Market Revenue, by Indication (2017-2030)
9.5. Market Revenue, by End User (2017-2030)
9.6. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

10.1. Overview
10.2. Market Revenue, by Product Type (2017-2030)
10.3. Market Revenue, by Application (2017-2030)
10.4. Market Revenue, by Indication (2017-2030)
10.5. Market Revenue, by End User (2017-2030)
10.6. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

11.1. Overview
11.2. Market Revenue, by Product Type (2017-2030)
11.3. Market Revenue, by Application (2017-2030)
11.4. Market Revenue, by Indication (2017-2030)
11.5. Market Revenue, by End User (2017-2030)
11.6. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

12.1. Overview
12.2. Market Revenue, by Product Type (2017-2030)
12.3. Market Revenue, by Application (2017-2030)
12.4. Market Revenue, by Indication (2017-2030)
12.5. Market Revenue, by End User (2017-2030)

Chapter 13. Canada Market

13.1. Overview
13.2. Market Revenue, by Product Type (2017-2030)
13.3. Market Revenue, by Application (2017-2030)
13.4. Market Revenue, by Indication (2017-2030)
13.5. Market Revenue, by End User (2017-2030)

Chapter 14. Germany Market

14.1. Overview
14.2. Market Revenue, by Product Type (2017-2030)
14.3. Market Revenue, by Application (2017-2030)
14.4. Market Revenue, by Indication (2017-2030)
14.5. Market Revenue, by End User (2017-2030)

Chapter 15. France Market

15.1. Overview
15.2. Market Revenue, by Product Type (2017-2030)
15.3. Market Revenue, by Application (2017-2030)
15.4. Market Revenue, by Indication (2017-2030)
15.5. Market Revenue, by End User (2017-2030)

Chapter 16. U.K. Market

16.1. Overview
16.2. Market Revenue, by Product Type (2017-2030)
16.3. Market Revenue, by Application (2017-2030)
16.4. Market Revenue, by Indication (2017-2030)
16.5. Market Revenue, by End User (2017-2030)

Chapter 17. Italy Market

17.1. Overview
17.2. Market Revenue, by Product Type (2017-2030)
17.3. Market Revenue, by Application (2017-2030)
17.4. Market Revenue, by Indication (2017-2030)
17.5. Market Revenue, by End User (2017-2030)

Chapter 18. Spain Market

18.1. Overview
18.2. Market Revenue, by Product Type (2017-2030)
18.3. Market Revenue, by Application (2017-2030)
18.4. Market Revenue, by Indication (2017-2030)
18.5. Market Revenue, by End User (2017-2030)

Chapter 19. Japan Market

19.1. Overview
19.2. Market Revenue, by Product Type (2017-2030)
19.3. Market Revenue, by Application (2017-2030)
19.4. Market Revenue, by Indication (2017-2030)
19.5. Market Revenue, by End User (2017-2030)

Chapter 20. China Market

20.1. Overview
20.2. Market Revenue, by Product Type (2017-2030)
20.3. Market Revenue, by Application (2017-2030)
20.4. Market Revenue, by Indication (2017-2030)
20.5. Market Revenue, by End User (2017-2030)

Chapter 21. India Market

21.1. Overview
21.2. Market Revenue, by Product Type (2017-2030)
21.3. Market Revenue, by Application (2017-2030)
21.4. Market Revenue, by Indication (2017-2030)
21.5. Market Revenue, by End User (2017-2030)

Chapter 22. Australia Market

22.1. Overview
22.2. Market Revenue, by Product Type (2017-2030)
22.3. Market Revenue, by Application (2017-2030)
22.4. Market Revenue, by Indication (2017-2030)
22.5. Market Revenue, by End User (2017-2030)

Chapter 23. South Korea Market

23.1. Overview
23.2. Market Revenue, by Product Type (2017-2030)
23.3. Market Revenue, by Application (2017-2030)
23.4. Market Revenue, by Indication (2017-2030)
23.5. Market Revenue, by End User (2017-2030)

Chapter 24. Brazil Market

24.1. Overview
24.2. Market Revenue, by Product Type (2017-2030)
24.3. Market Revenue, by Application (2017-2030)
24.4. Market Revenue, by Indication (2017-2030)
24.5. Market Revenue, by End User (2017-2030)

Chapter 25. Mexico Market

25.1. Overview
25.2. Market Revenue, by Product Type (2017-2030)
25.3. Market Revenue, by Application (2017-2030)
25.4. Market Revenue, by Indication (2017-2030)
25.5. Market Revenue, by End User (2017-2030)

Chapter 26. Saudi Arabia Market

26.1. Overview
26.2. Market Revenue, by Product Type (2017-2030)
26.3. Market Revenue, by Application (2017-2030)
26.4. Market Revenue, by Indication (2017-2030)
26.5. Market Revenue, by End User (2017-2030)

Chapter 27. South Africa Market

27.1. Overview
27.2. Market Revenue, by Product Type (2017-2030)
27.3. Market Revenue, by Application (2017-2030)
27.4. Market Revenue, by Indication (2017-2030)
27.5. Market Revenue, by End User (2017-2030)

Chapter 28. U.A.E. Market

28.1. Overview
28.2. Market Revenue, by Product Type (2017-2030)
28.3. Market Revenue, by Application (2017-2030)
28.4. Market Revenue, by Indication (2017-2030)
28.5. Market Revenue, by End User (2017-2030)

Chapter 29. Competitive Landscape

29.1. List of Market Players and their Offerings
29.2. Competitive Benchmarking of Key Players
29.3. Product Benchmarking of Key Players
29.4. Recent Strategic Developments

Chapter 30. Company Profiles

30.1. Thermo Fisher Scientific Inc.
- 30.1.1. Business overview
- 30.1.2. Product and service offerings
- 30.1.3. Key financial summary
30.2. Puritan Medical Products LLC
- 30.2.1. Business overview
- 30.2.2. Product and service offerings
30.3. Becton, Dickinson and Company
- 30.3.1. Business overview
- 30.3.2. Product and service offerings
- 30.3.3. Key financial summary
30.4. COPAN Diagnostics Inc.
- 30.4.1. Business overview
- 30.4.2. Product and service offerings
30.5. Laboratory Corporation of America Holdings
- 30.5.1. Business overview
- 30.5.2. Product and service offerings
- 30.5.3. Key financial summary
30.6. HiMedia Laboratories Pvt. Ltd.
- 30.6.1. Business overview
- 30.6.2. Product and service offerings
30.7. Trinity Biotech plc
- 30.7.1. Business overview
- 30.7.2. Product and service offerings
- 30.7.3. Key financial summary
30.8. EKF Diagnostics Holdings plc
- 30.8.1. Business overview
- 30.8.2. Product and service offerings
- 30.8.3. Key financial summary
30.9. Alpha Teknova Inc.
- 30.9.1. Business overview
- 30.9.2. Product and service offerings
- 30.9.3. Key financial summary
30.10. Vircell S.L.
- 30.10.1. Business overview
- 30.10.2. Product and service offerings
30.11. Medical Wire & Equipment
- 30.11.1. Business overview
- 30.11.2. Product and service offerings
30.12. Lucence Health Inc.
- 30.12.1. Business overview
- 30.12.2. Product and service offerings
30.13. Merck KGaA
- 30.13.1. Business overview
- 30.13.2. Product and service offerings
- 30.13.3. Key financial summary
30.14. Wuxi AppTec Co. Ltd.
- 30.14.1. Business overview
- 30.14.2. Product and service offerings
- 30.14.3. Key financial summary
30.15. Bio-Rad Laboratories Inc.
- 30.15.1. Business overview
- 30.15.2. Product and service offerings
- 30.15.3. Key financial summary

Chapter 31. Appendix

31.1. Abbreviations
31.2. Sources and References
31.3. Related Reports

Transport Media Market Size and Share Analysis by Product Type, Application, Indication, End User - Global Industry Demand Forecast to 2030